Waggoner D J, Towbin J, Gottesman G, Gutmann D H
Department of Medical Genetics, Neurofibromatosis Program, St. Louis Children's Hospital, St. Louis, Missouri, USA.
Am J Med Genet. 2000 May 15;92(2):132-5.
Individuals with neurofibromatosis 1 (NF1) develop both benign and malignant tumors at an increased frequency. One of the most common benign tumors in NF1 is the plexiform neurofibroma. These tumors cause significant morbidity and mortality on account of their propensity to grow and affect adjacent normal tissues. To determine the clinical profile of plexiform neurofibromas in NF1, we conducted a retrospective review of 68 NF1 patients with plexiform neurofibroma. In our series, 44% of tumors were detected by 5 years of age and most were located in the trunk and extremities. Only two patients developed malignant peripheral nerve sheath tumors in their preexisting plexiform neurofibromas. Lastly, we demonstrate that there were no specific clinical features of NF1 associated with the presence of plexiform neurofibroma. These results underscore the importance of careful serial examinations in the evaluation of patients with NF1.
患有1型神经纤维瘤病(NF1)的个体发生良性和恶性肿瘤的频率增加。NF1中最常见的良性肿瘤之一是丛状神经纤维瘤。这些肿瘤因其生长倾向和影响邻近正常组织的特性而导致显著的发病率和死亡率。为了确定NF1中丛状神经纤维瘤的临床特征,我们对68例患有丛状神经纤维瘤的NF1患者进行了回顾性研究。在我们的系列研究中,44%的肿瘤在5岁时被检测到,大多数位于躯干和四肢。只有两名患者在其先前存在的丛状神经纤维瘤中发生了恶性外周神经鞘瘤。最后,我们证明没有与丛状神经纤维瘤存在相关的NF1特异性临床特征。这些结果强调了在评估NF1患者时进行仔细的系列检查的重要性。